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Abstract
Introduction and hypothesis The objective of our studywas to
estimate the incidence and to identify the risk factors for reop-
eration of surgically treated stress urinary incontinence (SUI).
Methods We conducted a nested case-control study among
1,132 women who underwent SUI surgery from January
1988 to June 2007. Cases (n035) were women who re-
quired reoperation for SUI following the first intervention
up to December 2008. Controls (n089) were women ran-
domly selected from the same cohort who did not require
reoperation.
Results The cumulative incidence of SUI reoperation was
3.1 % with a mean follow-up of 10.9 years (range 1.7–21.0).
The main risk factor was the history of more than one
vaginal delivery [adjusted odds ratio (OR) 3.5; 95 % confi-
dence interval (CI) 1.0–12.6]. The use of synthetic midure-
thral slings was a protective factor compared to other
surgical procedures for urinary incontinence (adjusted OR
0.1; 95 % CI 0.0–0.6).
Conclusions The risk of reoperation after SUI surgery
appears to be low and associated with multiple vaginal
deliveries. Synthetic slings at index surgery are associated
with a lower risk of reoperation.
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Abbreviations
SUI Stress urinary incontinence
UI Urinary incontinence
MUS Midurethral slings
OR Odds ratio
CI Confidence interval
BMI Body mass index
HRT Hormone replacement therapy
POP Pelvic organ prolapse
ISD Intrinsic sphincter deficiency
TVT Transvaginal tape
TOT Transobturator tape
NA Not applicable
Introduction
Urinary incontinence (UI) is a major public health problem.
It is a common condition that affects almost one of two
women in the USA and often impairs social, physical, and
psychological well-being [1]. In Europe, it is estimated to
affect up to one third of women older than 18 years. The
prevalence increases with age and reaches 45 % at 60 years
[2]. With the aging of populations worldwide, we can expect
an increase of surgical treatment for UI in the near future.
The lifetime risk of undergoing UI surgery by age 80 was
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reported to be 3.6 % [3]. This rate is low compared to the
high prevalence and probably due to the fact that most
women with UI are ashamed of their condition and do not
seek help [2]. The management of recurrent UI after surgery
is challenging. Repeat surgery may be associated with lower
success and higher complication rate. The rate of reopera-
tion was reported to be 8.6 and 8.8 % in two recent studies
in the USA and in the UK [3, 4]. Very little is known about
the factors associated with surgical failure. Old age, higher
body mass index (BMI), diabetes, previous incontinence
surgery, concurrent prolapse surgery, and intrinsic sphincter
deficiency (ISD) are potential risk factors [5–10]. However,
data vary largely between studies and results are sometimes
contradictory concerning the role of risk factors such as age
or BMI for example. When comparing surgical techniques,
slings were protective factors compared to abdominal retro-
pubic operations in one study, but were associated with
poorer results in another one [3, 4].
The purpose of this study was to estimate the incidence
and identify the risk factors for stress urinary incontinence
(SUI) reoperation after previous SUI surgery.
Materials and methods
We performed a case-control study nested within a co-
hort. This study was approved by the Institutional Ethics
Committee of the Geneva University Hospitals (protocol
number 09-252R). We identified, by using a computer-
ized medical record database, all women (n01,132) who
underwent SUI surgery in the Department of Obstetrics
and Gynecology, Geneva University Hospitals, from Jan-
uary 1988 to June 2007. This is a teaching hospital,
where all women had their operation performed either
by a supervised resident in gynecological surgery or by
an experienced gynecological surgeon (consultant, profes-
sor). Cases (n035) were women of this cohort who
required reoperation for recurrent SUI following the first
intervention through December 2008 in our institution.
Because our hospital is the only public institution in the
canton of Geneva and women needing a reoperation
cannot be treated either outside the canton or in private
institutions, we believe that most cases were identified
using this strategy. Controls (n089) were patients, ran-
domly selected from the same cohort, who did not re-
quire reoperation for SUI during the same period. We
selected all cases and drew a sample of controls (two
controls per case) from the hospital database which
includes all women who had SUI surgery. We calculated
that a sample size of 102 women with 34 cases and 68
controls had a power of 80 % with a two-tailed alpha of
0.05 to demonstrate statistical significance of odds ratios
(ORs) of 4, in a plausible range of probability of exposure to a
risk factor. We selected a few more controls to reach the
desired number in case of unavailable medical charts.
To avoid bias in the evaluation of risk factors, data were
collected from the medical charts blinded to the study group.
The medical charts were photocopied and stripped of patient
identity. The part concerning the first intervention was sepa-
rated from that of the second in cases. One of the authors
(C.L.) reviewed all of the medical charts related to the first
intervention (124 surgically treated SUI) and another (P.D.)
reviewed the charts related to the second intervention (35
reoperations for recurrent SUI). Variables extracted from the
charts included age, weight, height, parity, number of vaginal
deliveries, previous caesareans, menopausal status, hormone
replacement therapy, smoking, constipation, chronic obstruc-
tive pulmonary disease, cardiovascular disease, and history of
surgery for genital prolapse or UI performed outside our
institution or outside the study period. All women had a
standardized preoperative assessment including urodynamics
in most cases and pelvic organ prolapse (POP) quantification
using the Baden-Walker classification, which was the classi-
fication system used in our institution during the study period
[11]. The grade of cystocele, uterine or vaginal vault prolapse,
rectocele, and enterocele were identified as well as the grade
of SUI according to the Ingelman-Sundberg scale [12]. The
dates of SUI surgeries as well as the route (abdominal, vagi-
nal, or laparoscopic), the techniques, and the associated inter-
ventions (POP repair, hysterectomy) were collected. The
surgical techniques used in our institution for SUI over the
study period included Marshall-Marchetti and Burch colpo-
suspension as described by Hirsch et al. [13]. Women were
also treated with pubovaginal slings consisting of the intro-
duction (primarily through a vaginal approach) of a band of
nonsynthetic biological material (Lyodura: lyophilized irradi-
ated dura mater of human cadaver and pork fascia) beneath the
urethra at either the bladder neck or the midurethra. The other
incontinence procedures were retropubic and transobturator
synthetic midurethral slings [transvaginal tape (TVT), trans-
obturator tape (TOT)] as described by Ulmsten et al. [14] and
Delorme [15]. During the study period, between 2003 and
2004, a few patients were also treated at index procedure with
periurethral injections of a bulking agent (L-polylactic acid,
New-Fill®). Postoperative complications such as hematoma,
fever, or vault abscess were systematically sought out.
Cases and controls were compared for the predictor varia-
bles mentioned above. Differences in proportions were tested
with the chi-square test or Fisher’s exact test. Differences in
continuous variables were tested using the t test. We per-
formed a univariable analysis to compute the ORs for each
predictor. Variables found to be statistically associated with
the outcome or clinically important were then entered into
logistic regression models to compute adjusted ORs. A P
value less than .05 was considered as statistically significant
and 95 % confidence intervals (CIs) were reported. Data were
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managed and analyzed with Epi Info 6 (Centers for Disease
Control and Prevention, Atlanta, GA, USA) and SPSS 18.0
statistical software (SPSS Inc., Chicago, IL, USA).
Results
Between January 1988 and June 2007, 1,132 consecutive
SUI surgeries were performed in our institution. Between
January 1988 and December 2008, 35 women of this cohort
were reoperated for subsequent SUI, presenting thereby a
cumulative incidence of 3.1 %. The mean interval between
operations was 4.1 years (range 2 months–17.4 years) in the
case group and the mean duration of follow-up was
10.9 years (range 1.7–21.0 years) in controls. The mean
time interval for repeat UI surgery varied according to the
type of index operation. It was 0.6 (0.3–1.2) years in the
periurethral injectables group, 3.4 (1.6–5.1) years in the
synthetic midurethral slings (MUS) group, 4.5 (0.2–17.4)
years in the abdominal colposuspension procedures group,
Fig. 1 Number of cases of
reoperation per ongoing year
Fig. 2 Cumulative incidence of
reoperation by incontinence
procedure
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and 5.1 (0.2–14.3) years in the nonsynthetic pubovaginal
slingplasty procedures group, respectively. The number of
cases per year of follow-up is shown in Fig. 1. Half of the
cases were reoperated within 2 years. To account for
temporal changes in the management of UI, the risk of
reoperation and the contribution of each technique were
evaluated for each year of follow-up (Fig. 2).
Cohort general characteristics and past medical history at
index surgery are described in Tables 1 and 2. The mean age
and the mean BMI were similar in both groups. Associated
POP at index surgery is described in Table 3. The stage of
POP assigned according to the most severe portion of the
prolapse did not differ between groups. Higher grade of SUI
was not associated with an increased risk of reoperation
(Table 4). There were no differences in postoperative com-
plications between groups. One patient presented a hemato-
ma and two patients had fever in the controls compared to
none in the cases. In univariable analysis, the history of two
or more vaginal deliveries was associated with a significant-
ly increased risk of SUI reoperation (OR 3.6; 95 % confi-
dence CI 1.2–11.1; P00.02). The history of POP repair (OR
5.33; 95 % CI 0.5–60.8; P00.19), the presence of ISD
(urethral closure pressure ≤20 cmH2O or Valsalva leak point
pressure ≤60 cmH2O) at urodynamics (OR 7.1; 95 % CI
0.7–70.6; P00.09), abdominal colposuspension (OR 1.5;
95 % CI 0.7–3.4; P00.32), and associated POP repair (OR
1.5; 95%CI 0.7–3.5;P00.39) or hysterectomy (OR 1.8; 95%
CI 0.8–3.9; P00.23) were all associated with an increased risk
of reoperation, but statistically, they were not significant
(Tables 2 and 4). Statistically significant risk factors included
the use of fascial slings (OR 7.2; 95 % CI 1.7–29.6; P00.005)
and periurethral bulking agents (P00.006). The use of syn-
thetic slings (transobturator or retropubic) was a protective
factor (OR 0.1; 95 % CI 0.0–0.4; P<0.001) (Table 5).
Table 1 Characteristics of the study population at first UI intervention
Cases
(n035)
Controls
(n089)
P
Age (years), mean (SD) 54.7 (12.4) 54.5 (11.3) 0.91
Height (cm), mean (SD) 159.9 (6.1) 158.0 (6.2) 0.13
Weight (kg), mean (SD) 70.8 (14.4) 68.2 (13.6) 0.34
BMI (kg/m2), mean (SD) 27.7 (5.07) 27.4 (5.4) 0.81
Menopause, n (%)a 17 (48.6 %) 49 (55.1 %) 0.55
HRT, n (%)a 11 (31.4 %) 21 (23.6 %) 0.17
Diabetes, n (%)a 0 3 (3.4 %) 0.56
Asthma or COPD, n (%)a 0 1 (1.1 %) 1.0
Smoking >5 cig./day, n (%)b 4 (11.4 %) 18 (20.2 %) 0.31
Cardiovascular disease, n (%) 4 (11.4 %) 23 (25.8 %) 0.09
Constipation, n (%)c 5 (14.3 %) 17 (19.1 %) 0.33
Sexual activity, n (%)c 23 (65.7 %) 48 (53.9 %) 0.20
P values are calculated with Fisher’s exact test for proportions and
with the t test for means unless specified
BMI body mass index, HRT hormone replacement therapy, COPD
chronic obstructive pulmonary disease
a There was one missing value in the case group
b There was one missing value in the case group
c There were 2 and 3 missing values in the case group and 12 and 20 in
the controls, with similar percentages for the 2 groups, for constipation
and sexual activity, respectively
Table 2 Risk factors for UI
reoperation: obstetric history and
previous pelvic surgery
P values are calculated with
Fisher’s exact test. Data are
presented as n (%)
OR odds ratio, CI confidence
interval, BMI body mass index,
POP pelvic organ prolapse
Predictor Cases
(n035)
Controls
(n089)
Unadjusted OR
(95 % CI)
P
BMI (kg/m2) ≥30 8 (22.9 %) 29 (32.6 %) 0.61 (0.3–1.5) 0.38
Parity, n (%)
Nulliparous 3 (8.6 %) 4 (4.5 %) Ref.
Multiparous 32 (91.4 %) 85 (95.5 %) 0.5 (0.1–2.4) 0.40
Vaginal delivery
None or one 4 (11.4 %) 28 (31.5 %) Ref.
Two or more 31(88.6 %) 61 (68.5 %) 3.6 (1.2–11.1) 0.02
Caesarean section
None 34 (97.1 %) 83 (93.3 %) Ref.
One or more 1 (2.9 %) 6 (6.7 %) 0.4 (0.0–3.6) 0.7
Previous incontinence surgery 1 (2.9 %) 3 (3.4 %) 0.8 (0.1–8.4) 1.0
Previous POP surgery 2 (5.7 %) 1 (1.1 %) 5.3 (0.5–60.8) 0.19
Previous POP or incontinence surgery
None 32 (91.4 %) 85 (95.5 %) Ref.
One or more 3 (8.6 %) 4 (4.5 %) 2.0 (0.4–9.4) 0.40
Previous hysterectomy 5 (14.3 %) 12 (13.5 %) 1.1 (0.4–3.3) 1.0
None 30 (85.7 %) 77 (86.5 %) Ref.
994 Int Urogynecol J (2013) 24:991–997
In multivariable analysis (Table 6), synthetic MUS
remained a protective factor compared to abdominal colpo-
suspension procedures. History of two or more vaginal
deliveries still increased the risk of reoperation for SUI.
The association between previous POP repair and an in-
creased risk of reoperation for UI remained high although
not statistically significant.
Discussion
Our study suggests that the risk of reoperation after SUI
surgery is low and associated with multiple vaginal deliver-
ies. Synthetic midurethral slings are associated with a lower
rate of reoperation compared to abdominal colposuspension
procedures or traditional pubovaginal biological slings.
We systematically searched MEDLINE (search terms:
“reoperation for surgically treated/managed stress urinary
incontinence, risk factors of repeat urinary incontinence
surgery, follow-up studies,” all languages, from 1966 to
2012) and found few studies reporting the incidence of
reoperation for recurrent SUI. Most authors measured a
combined risk of reoperation for surgically treated POP
and UI between 13 and 29 % [16, 17]. We found two
studies reporting reoperation rates for UI alone of 8.6
and 8.8 %, respectively, which is higher than our cumu-
lative incidence of 3.1 % [3, 4]. The incidence is influenced
by access to medical care and financial considerations, ren-
dering comparisons between different populations difficult.
The difference from the higher rates reported in the medical
literature may theoretically be explained by operations per-
formed outside our university clinic and not included in our
cohort, resulting in an underestimation of the real incidence.
However, that number is probably low as our clinic is
the only public institution in the canton of Geneva.
Women followed in public hospitals in Switzerland rarely
go to private clinics due to their lack of private health
insurance coverage, and Swiss health insurances only
exceptionally permit a patient to be operated in another
canton or country. We chose to evaluate surgically treated
recurrent SUI, as it represents the severe end of the
clinical spectrum. The incidence of SUI recurrence is
probably higher, but most women may find it tolerable
and therefore do not seek surgery.
Table 3 Description of preoperative POP at first intervention
Cases (n035) Controls (n089) Unadjusted OR
(95 % CI)
P
Any POP at first intervention 33 (94.3 %) 75 (84.3 %) 3.1 (0.7–14.3) 0.23
None 2 (5.7 %) 14 (15.7 %) Ref.
POP grade 2, 3, and 4 20 (57.1 %) 47 (52.8 %) 1.2 (0.5–2.6) 0.69
POP grade 0 and 1 15 (42.9 %) 42 (47.2 %) Ref.
Anterior compartment prolapse grade 3 and 4 7 (20 %) 9 (10.1 %) 2.2 (0.8–6.5) 0.15
Anterior compartment prolapse grade 2 or less 28 (80 %) 80 (89.9 %) Ref.
P values are calculated with Fisher’s exact test. Data are presented as n (%)
OR odds ratio, CI confidence interval
Table 4 Risk of reoperation according to preoperative grade of SUI and urodynamic measures
Age (years) Cases (n035) Controls (n089) Unadjusted OR
(95 % CI)
P
Grade 1 11 (31.4 %) 24 (27 %) Ref.
Grade 2 or 3 24 (68.6 %) 65 (73 %) 0.8 (0.3–1.9) 0.66
Grade 3 3 (8.6 %) 5 (5.6 %) 1.58 (0.4–7.0) 0.69
ISD (UCP≤20 cmH2O or VLPP≤60 cmH2O)
a 3 (8.8 %) 1 (1.4 %) 7.1 (0.7–70.6) 0.09
Transmission factors ≤50 %b 4 (14.3 %) 17 (23.9 %) 0.5 (0.2–1.7) 0.42
Associated urge incontinencec 13 (37.1 %) 27 (32.9 %) 1.2 (0.5–2.8) 0.68
P values are calculated with Fisher’s exact test. Data are presented as n (%).
OR odds ratio, CI confidence interval, ISD intrinsic sphincter deficiency, UCP urethral closure pressure, VLPP Valsalva leak point pressure
a Six patients in the control group did not have preoperative urodynamics
b Seven missing values in cases and 18 in controls
c Seven missing values in the controls
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Little is known about the risk factors that prevent or favor
recurrence and consecutive reoperation for SUI. Corroborating
our previous report which focused on reoperation for POP
surgery, we found that factors associated with the weakening
of the pelvic floor (previous POP or incontinence surgery,
associated POP surgery, or hysterectomy) were associated with
an increased risk of reoperation [18]. Results were however not
statistically significant, probably due to the small number of
cases. Daneshgari et al., in a case-control study, also found an
increased risk of recurrent SUI surgery in women with con-
comitant POP or pelvic floor repair [6]. In their study, age and
BMI were similar between groups and did not influence the
reoperation rate, which is similar to our findings.
An important finding of our study was that the number of
vaginal deliveries before initial surgery increased the risk of
reoperation. We hypothesize that each vaginal delivery weak-
ens the pelvic floor through muscular, fascia, and nerve
damage. Therefore, surgical procedures which may not restore
stable and long-lasting suburethral support are more likely to
fail. To limit the risk of reoperation, it might be important to use
a synthetic mesh to reinforce suburethral support rather than
biological material or sutures attached to an already weakened
pelvic floor, especially in case of multiple vaginal deliveries.
Similarly, in a large longitudinal study, Abdel-Fattah et al.
found that having more than two vaginal deliveries was an
independent risk factor for POP/UI surgery [3]. However,
contrary to our findings, it was not associated with UI reoper-
ation; the risk was slightly increased in those women with more
than two vaginal deliveries, but was not statistically significant.
In accordance with previous reports, ISDwas associatedwith
an increased rate of reoperation in our study, although the result
was not statistically significant [5]. We hypothesize that nerve
damage occurring during vaginal delivery may increase the risk
of a hypotonic urethra, thus increasing the risk of UI surgery
failure. Fialkow et al. in a large cohort study found that women
undergoing the Burch technique had a lower reoperation rate
than women undergoing slings [4]. However, in their study,
slings were a heterogeneous group combining native, biological,
and synthetic slings and the proportion of each was unknown.
We hypothesize that most of the slings described in this study
were probably nonsynthetic. Abdel-Fattah et al. in a recent study
also found a lower reoperation rate for MUS (3.2 %) compared
to abdominal retropubic surgery (10.7 %) [3].
It can be argued that the use of synthetic midurethral
slings is a newer procedure and has not been used in surgical
practice for as long as abdominal colposuspension proce-
dures and therefore the detected reduced risk may be subject
to bias. However, the mean interval for repeat UI surgery
was 3.4 years following synthetic slings compared to
4.5 years following abdominal colposuspension procedures,
and we believe that repeat surgery following synthetic MUS
is likely to have been captured within the time frame of this
Table 5 Type of intervention
Variable Cases (n035) Controls (n089) Unadjusted OR
(CI 95 %)
P
Synthetic slingplasty (TVT/TOT) 2 (5.7 %) 34 (38.2 %) 0.1 (0.0–0.4) <0.001
Nonsynthetic pubovaginal slingplasty 8 (22.9 %) 11 (12.4 %) 2.1 (0.8–5.8) 0.17
Abdominal colposuspension (Marshall-Marchetti or Burch) 21 (60 %) 44 (49 %) 1.5 (0.7–3.4) 0.32
Periurethral bulking agent 4 0 NA 0.006
Associated POP repair 13 (37.1 %) 25 (28.1 %) 1.5 (0.7–3.5) 0.39
Anterior colporrhaphy 8 (22.9 %) 20 (22.5 %) 1.0 (0.4–2.6) 1.0
Posterior colporrhaphy 5 (14.3 %) 8 (9.0 %) 1.7 (0.5–5.6) 0.52
Enterocele repair 1 (2.9 %) 1 (1.1 %) 2.6 (0.2–42.6) 0.49
Vault suspension 1 (2.9 %) 3 (3.4 %) 0.8 (0.1–8.4) 1.0
Associated hysterectomy 21 (60 %) 41 (46.1 %) 1.8 (0.8–3.9) 0.23
Data are presented as n (%). P values are calculated with Fisher’s exact test unless specified
OR odds ratio, CI confidence interval, TVT transvaginal tape, TOT transobturator tape, POP pelvic organ prolapse, NA not applicable
Table 6 Risk factors for UI reoperation: multivariable analysis. ORs
and 95 % CIs adjusted for the other factors in the model
Risk factor Adjusted OR
(95 % CI)
P
Age 1.0 (1.0–1.1) 0.63
BMI 1.0 (1.0–1.0) 0.58
History of two or more vaginal deliveries 3.5 (1.0–12.6) 0.05
History of POP repair 10.5 (0.6–175.2) 0.10
Type of surgery
Colposuspension (Burch, Marshall-Marchetti) Ref.
Synthetic slings (TVT, TOT) 0.1 (0.0–0.6) 0.01
Nonsynthetic slings 2.1 (0.7–6.2) 0.17
P values are calculated with the chi-square test unless specified. Each
OR and 95 % CI is adjusted for all other covariates listed in this table
OR odds ratio, CI confidence interval, BMI body mass index, POP
pelvic organ prolapse, TVT transvaginal tape, TOT transobturator tape
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study. Similarly, in the Abdel-Fattah et al. study, repeat UI
surgery also occurred earlier in the MUS group compared to
the retropubic abdominal procedures group [3].
The use of periurethral injectables was associated with an
increased risk of reoperation in our study which is comparable
to the findings reported by Adel Fattah et al. However, the
number of patients treated with this method was very small and
it is difficult to draw any firm conclusions. In contrast to the
findings of previous reports, diabetes was not a significant risk
factor in our study. However, the numbers were too small to
show any effect of this factor on the risk of reoperation, and we
thereby once again cannot draw any firm conclusions [5, 6].
The limitations of this study were the small number of cases,
thus rendering the multivariable analysis difficult to interpret.
The power of the study was also not sufficient to show statis-
tically significant differences for some of the risk factors such
as history of previous POP repair or ISD at urodynamics.
However, risk factors evaluated in the univariable analysis
and in the multivariable model showed the same magnitude
of association, although this was not statistically significant; we
believe this tendency to be of clinical significance.
The strength of this study was the availability of a con-
tinuously updated computerized register, which allowed us
to identify cases and controls in the same large cohort with a
long follow-up. Another strength was the preoperative stan-
dardized assessment, including urodynamics in most cases
and POP quantification. The assessment of SUI was more
reliable than in studies using questionnaires.
Based on our data and recent studies, we believe the risk
of reoperation for recurrence after SUI surgery to be be-
tween 3 and 9 %. It might be important to use synthetic
suburethral slings at index surgery, especially in women
with a history of multiple vaginal deliveries.
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